Pharma Sector: Q2FY24 Review
In Q2FY24, the Pharma Coverage universe posted robust revenue growth of 14.3%/1.7% YoY/QoQ on account of volume rampup, new launches (especially...
304 Views
Axis Research Scorecard Report for Oct 2023
Our POW calls delivered an excellent Monthly strike rate of 84% in Oct’23. Calls that successfully achieved their target were Nestle India (~10%),...
354 Views
Top Sector Ideas - Pharma
In Q1FY24, the Pharma Coverage universe posted robust revenue growth of 20.5%/6.1% YoY/QoQ on account of volume rampup, new launches (especially...
332 Views
Pick of the Week - CIPLA LTD - 14 AUG 2023
Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics and portfolio deepening in the India, South...
151 Views
CIPLA Ltd - Robust Performance Across All Parameters
Cipla reported the highest-ever US business of $222 Mn (+26% QoQ), which was primarily led by better execution in the base business and a higher...
279 Views